(b) Microspheres within a 1.5 μm slice were binned, the bin centre is shown.
(c) Each individual microsphere was localized and fitted with a 2D Gaussian curve, and the integrated intensity was calculated in each z-slice. The mean of the intensity data is shown; ± represents the standard deviation within each bin. (d) N is the number of single microspheres within each bin used to calculate the mean of the intensity data (e) HIV IN-eGFP was produced with the respective amount of Vpr-IN-eGFP plasmid per petri dish.
(f) Each individual viral particle was localized and fitted with a 2D Gaussian curve, and the integrated intensity was calculated in each z-slice. The mean of the intensity data is shown, ± represents the standard error of the mean (SEM). (g) N is the number of single viral particles used to calculate the mean of the intensity data. SCR= scrambled, BC= back-complemented). (c) Each individual viral complex was localized and fitted with a 2D Gaussian curve, the FRET ratio was calculated using Eq. 1. Typically data were collected from ~50-100 different cells corresponding to an average of ~500-3000 viral complexes. Shown here is the mean FRET ratio of all localized viral complexes (N). ± represents the standard error of the mean (SEM). Fig. S4 ). for the detection of the nuclear lamin is calculated using the triangle algorithm. (2) The middle, the inner and outer of the nuclear lamin (indicated by +++) is automatically detected based on intensity thresholding. The black and white image shows the assignment of the nuclear lamin. (3) Based on the nuclear lamin (blue), complexes are assigned to the cytoplasm (magenta) or nucleus (cyan). Right: (1) The point spread function of each spot is fitted with a 2D Gaussian function using the least-mean-square method, the residual after fitting is shown as well. Complexes with width (σ x and σ y ) larger than 2 pixels are excluded since these are assumed to be aggregates. 
SUPPLEMENTARY METHODS

Plasmids and siRNA transfections
The following reagents were obtained through the NIH AIDS Reagent Program, Division of AIDS, NIH: The Vpr-IN-eGFP construct is described in Albanese et al. 9 and both Vpr-IN-mTFP1 and Vpr-IN-mVenus plasmids are described in Borrenberghs et al.
10
. To verify expression and knock-down of LEDGF/p75 in their respective HeLaP4-derived cell lines, 3×10
(1/200 dilution, A300-848a, Bethyl Laboratories, Montgomery, TX) and goat anti-rabbit ATTO647N secondary antibody (1/500 dilution, Molecular Probes, Invitrogen). DNA was stained using DAPI (1/1000 dilution). % glycerol) and luciferase activity was measured using fLuc assay reagent (ONE-Glo TM Promega GMBH, Mannheim, Germany). Readouts were normalized for protein content as determined by the BCA-assay (BCA Protein Assay Kit, Thermo Scientific). Data are presented as relative infectivity compared to HIV; the standard deviation represents deviation of triplicates.
C8166 T cell culturing and infection
C8166 T cells (NIH AIDS
Quantitative PCR analysis of 2-LTR circles
Unlabeled VSV-G pseudotyped HIV was produced by seeding 6. 
